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There is little evidence that workshops alone have a lasting impact on the day-to-day practice of partici-
pants. The current paper examined a strategy to increase generalization and maintenance of skills in the 
natural environment using pseudo-patients and immediate performance feedback to reinforce skills acqui-
sition. A random half of pharmacies (N=30) took part in workshop training aimed at optimizing consumers’ 
use of nonprescription analgesic products. Pharmacies in the training group also received performance 
feedback on their adherence to the recommended protocol. Feedback occurred immediately after a pseu-
do-patient visit in which confederates posed as purchasers of analgesics, and combined positive and cor-
rective elements. Trained pharmacists were significantly more accurate at identifying people who misused 
the medication (P<0.001). The trained pharmacists were more likely than controls to use open-ended 
questions (P<0.001), assess readiness to change problematic use (P<0.001), and to deliver a brief inter-
vention that was tailored to the person’s commitment to alter his/her usage (P <0.001). Participants 
responded to the feedback positively. Results were consistent with the hypothesis that when workshop is 
combined with on-site performance feedback, it enhances practitioners’ adherence to protocols in the nat-
ural setting. 
INTRODUCTION 
Pseudo-patients studies are those in which a patient enters the 
health setting, not to seek treatment, but to observe and/or test 
the health care process. In previous pseudo-patient studies, the 
focus has been primarily on assessment of the practitioners’ 
skills. The current paper differs from these studies as pseudo-
patient methodology is used in a randomized trial as part of an 
educational program. 
Direct observations have a number of strengths as assess-
ments of practitioner behavior. They are conducted in the nat-
uralistic environment, rather than in artificial testing settings 
(such as role-played assessments in a workshop context). They 
focus on the key behaviors to be tested, rather than on proxy 
measures such as file records of interventions that are made by 
the practitioner. When the practitioner is not aware that the 
person is not a real patient, the method also minimizes the risk 
of the assessment being reactive (as can occur when an observ-
er is present or the interview is being taped)(1). However, the 
issue often induces some anxiety or resentment among practi-
tioners. Such resentment is particularly prone to occur if the 
observation is very critical or was undertaken without prior 
consent. It is felt that pseudo-patient research often results in 
very critical reports of practitioners’ behavior. 
Pseudo-patient studies have also been conducted to evalu-
ate training on pharmacy-based intervention(2) as self-report-
ed rates of intervention delivery would have been likely to be
inflated in relation to pseudo-patient observations. However, if 
pseudo-patient assessments were more fully integrated in the 
training, we might be able not only to derive an accurate 
assessment of changes in clinical practice, but we might be 
able to use feedback from the assessments as a basis for further 
skills acquisition. Some pseudo-patient studies in pharmacies 
have provided pharmacists with feedback from the assess-
ments, but these typically have been delayed(3). We know that 
performance feedback is most effective when it is provided 
immediately after the performance(4). The present study 
attempted to incorporate the assessment strengths of the pseu-
do-patient methodology, but used it in a collaborative manner 
to promote further skill development. 
The Use of Pseudo-Patients as an Educational Tool 
Continuing education of health professionals tends to rely 
on workshop training as a primary means of skill development. 
However, there is substantial evidence that workshops often 
have little lasting impact on the day-to-day practice of partici-
pants. The data cover areas as diverse as training general prac-
titioners to provide advice to stop smoking(5,6) and on rates of 
reminders about Pap smears(6), training mental health staff to 
deliver family intervention(7) and training health workers to 
develop and record behavioral patient goals(8). 
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Fig. 1. Intervention strategies for inappropriate users. 
There are several possible reasons for this failure to gen-
eralize skills. In some cases, participants may not be commit-
ted to skill acquisition when they attend the workshop; the pro-
cedure that is taught may not be suitable for implementation, or 
there may be insufficient incentives for implementation when 
participants attempt it in the field(7). Alternatively, the work-
shop may not include sufficient opportunity for skills practice 
with corrective feedback, or the skills practice may not be in a 
sufficiently similar context. Preliminary data collected by the 
authors reinforced the notion that a keen group of participants 
and a practical procedure were not enough to ensure continued 
application of the skills in the field(9). In the current paper, we 
examined a strategy to increase skills and incentives in the nat-
ural environment using pseudo-patients. A pilot study con-
ducted by the authors involved developing and testing the via-
bility of an intervention for inappropriate analgesic use that 
could be used in a retail context(10). In Australia, compound 
analgesics containing paracetamol, codeine and doxylamine 
are available to the public from a pharmacist without a medical 
prescription. However, pharmacists are legally required to 
deliver personally these analgesic products (“pharmacist-
only”) to the consumer. In the pilot study, the authors predict-
ed that an approach that provided immediate feedback to phar-
macists on the use of the intervention with their own con-
sumers of analgesics would maximize generalization to the 
natural setting and maintenance of the skills(10). In this pre-
vious study three hundred and twenty-one pseudo-patient vis-
its were used to assess, coach and motivate participants to 
deliver the pharmacy-based intervention. Baseline data collec-
tion and training were conducted over a period of 8 weeks. 
Results showed that compared with controls, the trained phar-
macists were significantly more likely to identify inappropriate 
analgesic use (P<.01) and were more likely to discuss the use 
of alternatives (P<0.02). The pseudo-patient methodology was 
successful in transferring training to the natural environment. 
Fourteen weeks after training these training effects on perfor-
mance were substantially maintained. However, adherence to 
legal requirements that the pharmacist personally deliver the 
“pharmacist-only” analgesics to consumers was initially high 
(Baseline and Training Phase) in both Control and Training 
groups, but decayed over time (Week-14 follow-up). This sug-
gested reactivity to knowledge that assessment was taking 
place. There were also limitations to this study: The data relied 
upon pseudo-patient recollection of the interaction with the 
pharmacist; training did not lead to an increase in referral for 
medical consultation when it was appropriate; and the rate of 
warning pseudo-patients about the effects of the medication 
fell with training on the behavioral intervention. 
METHOD 
The aim of the present study was also to change pharmacists’ 
behavior in relation to non-prescription compound analgesics. 
It took the methodology used in the pilot study a step further: 
More pharmacies were recruited [30]; a greater number of 
pseudo-patient visits were conducted [453]; the training period 
was extended to six weeks; audiotaping was used for greater 
accuracy of performance feedback; and training not only 
focused on behavioral techniques, but also stressed medical 
consultation when appropriate. The study also attempted to 
measure the impact of the intervention upon consumers. 
However because consumer response was poor, no meaningful 
analysis could be undertaken and this will not be reported. 
Subjects 
Forty-three pharmacists from 30 pharmacies were conve-
niently recruited to take part in the study. These pharmacies 
were randomly allocated to either a Training Group (n=15 
pharmacies) or a control group (n=15 pharmacies). Eighteen 
of the 30 pharmacies were from the Sydney Metropolitan Area 
and remaining 12 were from regional centers in commuting 
distance of Sydney (80 - 100 km north). The pharmacies were 
randomly selected between these two groups (Metropolitan 
Area and Regional centers). Twenty-three pharmacies were 
independently owned and seven were linked to pharmacy 
chains. Eleven of the pharmacies were located in busy shop-
ping centres and considered to be of high volume, with the 
remaining 19 pharmacies being of lower volume. After ran-
domization the two groups of pharmacies were roughly equiv-
alent on the above variables. 
Intervention 
A brief intervention was taught to pharmacists in the train-
ing group during a three-hour off-site workshop. The inter-
vention was based on the strategies reported by de Almeida 
Neto et al.(11) In the intervention, pharmacists prompted con-
sumers to talk about their medication use by asking an open-
ended question, e.g., “How are you doing with this product?” 
Closed-ended questions were only asked if consumers failed to 
provide relevant information after being asked an open-ended 
question. In case of misuse, the pharmacist delivered an inter-
vention tailored to the individual. The intervention strategies 
were based on principles of motivational inte 
In the study intervention, the pharmacist assesses the con-
sumer’s readiness to change by asking how s/he feels about the 
particular behavior (Figure 1) e.g.,. How do you feel about 
talking more than eight tablets a day? The consumer’s answer 
should give the pharmacist an indication of whether or not s/he 
is ready to change. The appropriate strategy can then be used. 
If the consumer is not ready to change the pharmacist provides 
information about the inappropriate use in a nonconfrontation-
al manner in order to raise the consumer’s awareness about the 
behavior. If the consumer is ready to change, the pharmacist 
provides him/her with practical advice on how to go about 
changing (Figure 1). The intervention was practiced in role-
plays and pharmacists were requested to use it for sales of non-
prescription analgesic products containing paracetamol, 
codeine and doxylamine. 
Procedure 
Throughout the study, practice was monitored in all the 
pharmacies through the use of pseudo-patient visits. 
Confederates of the researchers went to the pharmacies and
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made test purchases of non-prescription products without dis-
closing their identity. The concept of pseudo-patient visits was 
presented to pharmacists as an integral part of the training pro-
gram with the purpose of coaching pharmacists in the process 
of developing the intervention skills. The methodology was 
negotiated with the pharmacists prior to study commencement 
and prior to allocation to either a control or an intervention 
group. All pharmacists knew they would be visited. Signed 
consent to collect the data was obtained from all pharmacists in 
the study. Pharmacists’ awareness of pseudo-patron evaluation 
was an integral component of the training program. This 
awareness was needed to motivate continued application of the 
intervention in the field. 
There were two assessment phases: During an initial three-
week baseline period and for six weeks immediately after 
workshop training when pharmacists in the training group 
received performance feedback (Post). The responses of con-
trol pharmacists to the pseudo-patients were assessed in the 
same way as for the training group, but no feedback on perfor-
mance was given. All interactions with the pharmacists were 
audiotaped using a small tape recorder concealed by the pseu-
do-patient. 
All pseudo-patients were instructed to play the role of an 
inappropriate medication user. Three scripts were chosen and 
rotated throughout the study: (i) dosage above manufacturers’ 
recommendation; (ii) inappropriate indication of medication; 
and (iii) prolonged use without adequate supervision. The sce-
narios were based on the findings of previous unpublished 
research1, which identified these scenarios as areas of pharma-
cist concern(1). The time of the pseudo-patron visit was also 
randomly rotated throughout the study. 
All pseudo-patients were instructed to provide informa-
tion about medication behavior only if the pharmacist inquired 
about it. If the pharmacist asked an open-ended question, 
pseudo-patients were to provide all relevant information about 
their drug-taking behavior. In the case of close-ended ques-
tions, pseudo-patients were to provide only information per-
taining to the question. All pseudo-patients were trained prior 
to visiting the pharmacies, using role-play with provision of 
feedback. In order to avoid being recognized as a pseudo-
patient, confederates visited a particular pharmacy only once 
during the study, 
Immediately following a pseudo-patient visit, a researcher 
walked into the pharmacy and provided the training group 
pharmacist with positive feedback, emphasising positive fea-
tures of the pharmacist’s performance. Then the researcher 
offered corrective feedback or coaching that addressed how the 
pharmacist could improve performance further. A feedback 
sheet was designed highlighting essential features of the inter-
vention (clinical assessment, assessment of readiness to 
change, and use of an appropriate strategy) to facilitate provi-
sion of standardised feedback. On this sheet the components 
of the intervention that a pharmacist performed well were 
checked and the ones requiring further training were left blank. 
A carbon copy of the assessment sheet was given to the phar-
macist. In pharmacies that had more than one pharmacist feed-
back was provided to the pharmacist who interacted with the 
pseudo-patron. At the end of the study all pharmacists in the 
study pharmacies had been through training and positive 
reevaluation. 
1Benrimoj, S.I. and Chetcuti, N.L., “Pharmacoepidemiology of 
Nonprescription Analgesic Products,” The University of Sydney, Sydney 
(1994) unpublished. 
A total of 453 pseudo-patient visits were conducted. Of 
these, 153 visits were conducted during Baseline (range = 4 - 6  
visits, median = 6) and 300 during the training period (range = 
8 - 13 ,  median = 12). Because of variations in the number of 
visits across phases of the study, the primary analyses of 
changes in pharmacist behavior were based on the proportion 
of visits in each phase when a particular behavior was 
observed. 
The pseudo-patient visits provided observations on 11 
measures. The measures which were directly related to the 
intervention and which therefore were expected to change 
more strongly in the training group than the controls were as 
follows: (i) use of open-ended questions; (ii) identification of 
misuse; (iii) assessment of readiness to change; (iv) Provision 
of information on misuse; (v) Discussion of alternate medica-
tion and; (vi) and suggesting that the patron consult a doctor. 
Five others were expected to be already within the pharma-
cists’ knowledge and skill repertoire: (i) personal delivery of 
medication by the pharmacist; (ii) asking if the consumer had 
used the medication before; (III) warning about drowsiness; 
(iv) warning about alcohol interactions; (v) and warning the 
patron not to drive. These were not expected to change differ-
entially as a result of training, even though the workshop 
included reminders about some of these elements. Instead, 
awareness of the pseudo-patient visits over the course of the 
study was expected to make a temporary impact on pharmacist 
adherence to these behaviors across both training and control 
groups. 
After training had finished, acceptability of the pseudo-
patient procedure was measured by sending to each pharmacist 
in the training group a survey questionnaire and pre-paid 
addressed envelope. To minimize bias, the responses were 
anonymous. A question about the pseudo-patient methodology 
was embedded in a set of more general questions to conceal the 
main purpose of the survey. The survey asked for some ratings 
on how much they liked the overall training, the practicability 
of the intervention, how much they liked the pseudo-patient 
training and feedback, and how much they liked the study 
intervention. Two open-ended questions were also asked: 
“What did you like about the training?” and “What did you 
NOT like about the training?”. 
To determine inter-rater reliability, an independent asses-
sor re-coded 15 percent of pharmacist/pseudo-patron interac-
tions. The investigator who did the coding also re-coded 15 
percent of his data to determine intra-rater reliability. 
RESULTS 
Of the 30 pharmacies three withdrew from the study during 
baseline phase. One pharmacy withdrew for health reasons 
and two pharmacies because of time constraints, leaving the 
training group with 13 and the control group with 14 pharma-
cies. 
Assessment of Information Needs 
The use of open-ended questions replaced the closed ques-
tion about past use, and allowed the pharmacist to obtain the 
same information, but with additional data about the patron’s 
misuse. 
Pharmacists in the study generally asked if the consumer 
had taken the medication before. On average, this question 
was asked at 59.5 percent of visits at Baseline, across groups. 
The frequency of this question decreased at Post to an average 
of 44.2 percent of visits (F(1, 25) = 8.95, P< 0.05). This was
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Table I. Proportion of pseudo-patient visits where selected Pharmacist behaviors were displayed over the 
course of the study 
 
Mean (SD) 
Control group pharmacies Training group pharmacies 
 
Baseline Post Baseline Post 
Used an open-ended question 0.03 0.13 0.02 0.68 
 (0.10) 0.17 (0.06) (0.24) 
Correctly identified misuse 0.10 0.17 0.16 0.67 
 (0.23) (0.19) (0.26) (0.20) 
Assessed readiness to change 0.00 0.09 0.01 0.47 
 (0.00) (0.24) (0.04) (0.26) 
Provided information on misuse 0.12 0.13 0.19 0.59 
 (0.19) (0.19) (0.16) (0.24) 
Discussed alternate medication 0.04 0.14 0.12 0..52 
 (0.18) (0.19) (0.18) (0.23) 
Provided practical advice 0.12 0.19 0.13 0.66 
 (0.21) (0.24) (0.18) (0.23) 
Recommended that see a doctor 0.06 0.11 0.04 0.33 
 (0.12) (0.17) (0.08) (0.19) 
Medication delivered by pharmacist 0.81 0.77 0.70 0.88 
 (0.17) (0.18) (0.31) (0.18) 
Discussed     
Drowsiness 0.57 0.49 0.55 0.26 
 (0.22) (0.20) (0.27) (0.15) 
Driving risk 0.18 0.17 0.36 0.15 
 (0.21) (0.18) (0.31) (0.14) 
Alcohol interaction 0.02 0.03 0.15 0.04 
 (0.06) (0.07) (0.21) (0.14) 
Asked about previous use of the medication 0.61 0.59 0.58 0.28 
 (0.24) (0.19) (0.26) (0.18) 
Results are based on 14 control and 13 trained pharmacists. 
primarily due to a decrease in the frequency of this question in 
the training group (Group x Time effect: F(1,25) = 7.33, P< 
0.02). Mean results of pharmacy observations for the training 
and control groups are displayed in Table I. 
As predicted, the use of open-ended questions increased 
from 0.03 percent at Baseline to 39.5 percent at Post (F(1,25) 
= 113.32, P< 0.001). This was mainly due to an increase in the 
use of open-ended questions by the training group from 0.03 
percent at baseline to 68.0 percent at post (Group x Time 
effect: F(1,25) = 63.72, P< 0.001). 
Legal Requirement 
The most basic expectation of the pharmacists was that 
they adhered to the legal requirement that they personally 
deliver the “pharmacist only” analgesic products to the pur-
chaser. As this should be well known to the pharmacist before 
the study, we predicted that it would be responsive to pharma-
cists’ awareness that assessment would occur at unpredictable 
intervals during the study. At Baseline the whole sample deliv-
ered the medication personally to an average of 75.7 percent of 
purchasers. The rate of adherence was 82.1 percent of pur-
chases at Post (F(1,25) = 3.64, n.s.) and there was an addi-
tional effect from training (Group x Time effect: F(1,25) = 
9.01, P < 0.01) with the rate increasing in the Training and 
decreasing in the control group (Table I). 
Misuse Identification 
Across groups, there was significant improvement from 
Baseline to Post in the proportion of visits on which misuse of 
medication was identified (F(1, 25) = 55.80, P<0.001). As 
expected, there was an effect of training (F(1,25) = 32.97, P >
0.001), which was primarily due to an increase in the rate of 
misuse identification by the training group from 16.2 percent at 
baseline to 66.9 percent at Post. 
Readiness to Change 
Once misuse was identified, pharmacists assessed the con-
sumer’s readiness to change by asking how s/he felt about the 
behavior in question. Out of the 67 percent of post visits to the 
training group in which misuse was identified, readiness to 
change was assessed 69.1 percent of the time with a significant 
effect of training (F(1,25) = 14.58, P < 0.001). 
The training and control groups differed in the rate of mis-
use identification when the pseudo-patient played the role of a 
consumer who was ready to change, “ready scenarios” (Table 
II, F(1,25) = 21.56, P<0.001). This was due to an increase in 
the rate of identification from baseline to post (F(1, 25) = 
26.85, P<0.001) with the training group presenting a greater 
rise over time (F(1, 25) = 14.16, P<0.001). 
A similar result was observed with the “not ready scenar-
ios”. The rate of identification of misuse differed between the 
two groups (Table II, F(1, 25) = 8.00, P <0.01) with an increase 
from baseline to post (F(1, 25) = 58.14, P <.001). Again, a 
greater rise over time was observed in the training group (F(1, 
25) = 37.99, P<0.001). 
Intervention for Medication Misuse 
Once the pharmacist determined whether or not the con-
sumer was ready to change he/she would then either provide 
information on misuse of the medication to those who were not 
ready and practical skills on how to go about changing to those 
who were ready. Changes in performance were obtained on the 
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Table II. Average percentage of visits per type of scenario on which misuse was identified. 
 
Control group pharmacies (n=14) Training group pharmacies (n = 13) 
Scenario Baseline Post Baseline Post 
Ready to change 









Results are based on a total of 543 visits to pharmacies. 
provision of information about the particular medication mis-
use (F(1,25) = 29.96, P < 0.001) with an effect of training 
(Group x Time effect: (F(1,25) = 28.04, P < 0.001). In 76.2 
percent of visits to the training group on which misuse was 
identified and the pseudo-patient was not ready to change, 
information on the misuse was provided in 76.2 percent of 
time. Such information comprised: Warning about the addic-
tive or constipating properties of codeine when taken in excess 
of label specifications; and/or explaining what the substances 
in the tablets were for (paracetamol, codeine and doxylamine), 
especially in case of non-analgesic use of the medication; 
and/or risks of hepatic side effects. 
There was also a significant increase across the whole 
sample from Baseline to Post in the proportion of visits on 
which an alternate medication was suggested by the pharmacist 
(F(1,25) = 32.58, P < 0.001). The use of an alternate medicine 
was discussed by the training group on 51.5 percent of visits at 
Post, compared with 11.8 percent at Baseline (Group x Time 
effect: F(1,25) = 12.94, P < 0.001). Out of the visits at Post to 
training group pharmacists on which the pseudo-patient was 
ready to change, a more appropriate medication was suggested 
65.5 percent of time. 
At Baseline only 0.05 percent of the whole sample sug-
gested that the pseudo-patient consult a general practitioner. 
This rate rose to 21 percent at Post (F(1,25) = 28.86, P < 
0.001). This effect was primarily due to an increase in the rate 
of suggestion to see a General Practitioner by the training 
group rather than to changes in controls (Group x Time effect: 
F(1,25) = 15.33, P > 0.001). However, practical advice, which 
encompassed suggesting a medical consultation, suggesting an 
alternate medication or treatment, was provided on 69.6 per-
cent of visits when the pseudo-patient played the role of a con-
sumer who was ready to change. 
Specific Warnings About Effects of the Medication 
A differential change across the groups from baseline to 
post was observed in the provision of specific warnings about 
medication effects, i.e., possible interaction with alcohol 
(F(1,25) = 5.25, P < 0.05), risk of driving a motor vehicle 
(F(1,25) = 9.22, P < 0.01) and about the drowsiness effect 
(F(1,25) = 19.64, P < 0.001). These effects were due to a 
greater decrease in warning by the training group than in con-
trols (Group x Time effect: F(1, 25) = 6.25, P < 0.02; F(1,25) 
= 7.95, P < 0.01; F(1,25) = 6.93, P < 0.02, respectively). 
Inter and Intra-rater Reliability 
The k values for inter-rater reliability exceeded 0.8 for the 
all the items on the rating scale. The k values for intra-rater 
reliability exceeded 0.8 for all items for both coders. 
Acceptability of Pseudo-Patient Procedure 
Out of 17 questionnaires sent to pharmacists in the train-
ing group 10 were returned to the researchers. Pharmacists 
were asked to rate on a 11-point likert scale how much they
enjoyed the pseudo-patient and feedback training (0 = not at all 
and 10 = very much). Ratings had a median of 9 (Range = 3-
10 and Mean = 7.7), and nine of the ratings were at 5 or above. 
CONCLUSIONS 
In direct contrast to previous pseudo-patient studies, a high 
proportion of pharmacists accepted the procedure. As the pro-
cedure had been negotiated with pharmacists, there was no 
sense of betrayal. Instead, participants recognized they would 
also profit from the procedure by further developing their pro-
fessional skills. 
The results were consistent with the hypothesis that when 
a workshop is combined with on-site performance feedback, it 
enhances in the natural setting practitioners’ adherence to pro-
tocols. Trained pharmacists showed significant improvement 
on all components of the protocol. 
Consistent with the previous study, there was a decrease in 
the rate of provision of clinical information about the analgesic 
product, i.e., interaction with alcohol, drowsiness and the risk 
of driving. This may be because of limits on the time that a 
pharmacist spends with a patient. There may need to be a pri-
oritizing of what is needed at the moment of analgesic pur-
chase. Another possibility is that trained pharmacists were cor-
rectly identifying patients who needed information on adverse 
effects, and only gave such information to those consumers. 
However, a further possibility is that, in focusing on the need 
to change dysfunctional use, pharmacists neglected important 
clinical information. 
Contrary to prediction, the results did show an effect of 
training on the legal requirement that pharmacists personally 
deliver the “pharmacist only” analgesic product. For ethical 
reasons there could be no true baseline measure of personal 
provision of the medication when the pharmacists were 
unaware of the assessment. The differential effect across 
groups was best explained by an initial inflation of perfor-
mance that was related to awareness that they were being 
assessed and a subsequent decline in the control group due to 
habituation to the assessment. The same habituation did not 
occur in the training group because the feedback maintained a 
sensitisation to assessment. The results for personal delivery 
of the medication were in contrast to the previous study, which 
had shown a sustained increase. It could have been the case 
that in the previous study a third assessment phase at an unpre-
dictable time period sustained sensitisation to assessment for a 
longer period of time. Additional research is needed to estab-
lish whether this explanation is accurate. 
The results did show an effect of training on referrals to 
medical practitioners. The area of analgesic misuse is an inter-
professional one, requiring collaboration between community 
pharmacists and general practitioners. Greater involvement of 
pharmacists in the health care chain may lead to an improve-
ment in health outcomes. 
Questions about the long-term sustenance of this behavior 
are still to be answered. However previous research conduct-
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ed by the authors found that 14 weeks after training its effects 
were still detectable(10). This indicates that continuous appli-
cation of the intervention skills may lead to their incorporation 
into practice behavior. However, it should be pointed out that 
all observations may have been inflated by the fact that all 
pharmacists in the study were self-selected. It also remains to 
be seen whether or not a change in behavior would be observed 
when using a random sample of pharmacists instead of a self-
selected sample. Only then would one be comfortable in gen-
eralizing the conclusions of this study to pharmacists as a 
whole. 
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